Glucagon and Glucagon-Like Peptides–Animals
The Role of GLP-1 Receptor Signaling in Metabolic Changes after Roux-en-Y Gastric Bypass in Diet Induced Obese Rats
6/10/2012 9:30:00 AM
6/10/2012 9:45:00 AM
, ERIC P. SMITH, TODD GREER, JOSE BERGER, DAVID A.. D'ALESSIO,
Roux-en-Y gastric bypass (RYGB) is the gold-standard for bariatric surgery, and leads to sustained weight loss and rapid resolution of diabetes. RYGB is associated with an elevated postprandial secretion of glucagon-like peptide-1 (GLP-1), which has been proposed to mediate some of the metabolic improvements following RYGB. The present study sought to determine whether GLP-1 receptor signaling is required for the effects of RYGB on glucose homeostasis, food intake, and weight loss. Diet-induced obese rats had RYGB or sham surgeries, and were randomly allocated to chronic blockade of GLP-1 action by minipump infusion of the GLP-1 receptor antagonist Exendin-9,39 (Ex-9; 2 pmol/kg/min), or vehicle (Vh). Minipumps were implanted subcutaneously at the time of RYGB or sham operation and delivered treatment for 6 weeks. The four groups, sham-Vh (n=5), sham-Ex9 (n=4), RYGB-Vh (n=6) and RYGB-Ex9 (n=8) were tracked for food intake and body weight daily for 6 weeks. At 6 weeks, an oral glucose tolerance test (OGTT; 1.5g glucose/kg b.w.) was performed. RYGB led to a ~11% and 18% reduction of body weight and accumulative food intake, respectively, and these effects did not differ between Vh and Ex-9 treated rats. In sham rats, Ex-9 treatment led to a ~19% increase in the glucose AUC during the OGTT. In contrast, after RYGB, Ex-9 caused a ~99% increase (p<0.05) in glucose AUC. These results demonstrate that GLP-1 action has a disproportionate effect on the maintenance of glucose homeostasis following RYGB in diet induced obese rats. In contrast, increased postprandial GLP-1 is less likely to play a role in alteration of food intake and body weight after this procedure.
When adding presentations to your Itinerary, please click "Add Checked Selections to My Itinerary" on
page of your search results.
Authors listed in
are the presenting authors for those abstracts that have presentations.
American Diabetes Association
1701 North Beauregard Street
Alexandria, VA 22311
The Online Abstract Submission and Invitation System
© 1996 - 2013 Coe-Truman Technologies, Inc. All rights reserved.